Senzime AB (publ) (SNZZF)
OTCMKTS · Delayed Price · Currency is USD
0.6175
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Senzime AB Market Cap
Senzime AB has a market cap or net worth of $80.95 million as of February 12, 2026. Its market cap has increased by 11.84% in one year.
Market Cap
80.95M
Enterprise Value
70.64M
Revenue
9.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.62
Market Cap Chart
Since June 18, 2008, Senzime AB's market cap has increased from 5.90M to 80.95M, an increase of 1,272.05%. That is a compound annual growth rate of 15.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 78.30M | -15.24% |
| Dec 30, 2025 | 92.37M | 40.02% |
| Dec 30, 2024 | 65.97M | -25.20% |
| Dec 29, 2023 | 88.19M | 22.48% |
| Dec 30, 2022 | 72.00M | -54.29% |
| Dec 30, 2021 | 157.52M | -13.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 340.99M |
| Tian'an Technology Group | 182.07M |
| Zomedica | 127.05M |
| Positron | 68.49M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 55.94M |
| Guided Therapeutics | 33.69M |
| Vivos | 32.75M |